Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAH-ProMetGen: Biological Signatures of Occupational PAH Exposure
NCT05679544Recruiting
- Sponsor
- CHU Grenoble Alpes
- Start
- Apr 2023
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Grenoble Alpes. Primary endpoints: Deregulation of blood proteins expression due to exposure to PAHs up to 6 months, Deregulation of blood metabolites expression due to exposure to PAHs up to 6 months and 1 more. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05679544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05679544.